This study highlights the key role of Cys sulfinylation in the progression of liver fibrosis and identifies the SRXN1–PTPN12–NLRP3 axis as a critical regulator of liver fibrosis and a potential therapeutic target for intervention51. This evidence concerns the gene SRXN1 and Hepatic fibrosis.